Literature DB >> 21606575

Cognitive impairment in patients with Pseudotumor Cerebri Syndrome.

Siddharth Kharkar1, Robert Hernandez, Sachin Batra, Philippe Metellus, Argye Hillis, Michael A Williams, Daniele Rigamonti.   

Abstract

INTRODUCTION: Patients with Pseudotumor Cerebri Syndrome (PTCS) may complain of difficulty in thinking or concentrating; however there has been little formal cognitive evaluation in this population.
OBJECTIVE: To evaluate the characteristics and nature of cognitive impairment in patients with PTCS.
METHODS: We retrospectively reviewed records of 10 patients diagnosed with PTCS who were cognitively tested at presentation. In each cognitive test, "Borderline deficit" (BD) was defined as a score more than 1 standard deviation (SD) below and "Definite Deficit" (DD) as a score more than 2 SD below the mean for age, sex and education. In each cognitive domain, impairment was defined as a single test score more than 2 SD below the mean, or scores of more than 1 SD below the mean for age, sex and education in > 50% of tests.
RESULTS: Mean age of patients was 43.4 ± 13.5 years. 8/10(80%) patients were female. 3/10(30%) had papilledema; 3/10(30%) had significant cerebral venous outflow obstruction. Impairment was most commonly seen and was most severe in the WMS logical memory I (BD-44%, DD-44%), WMS logical memory II (BD-37.5%, DD-50%), RAVLT delayed recall (BD-30%, DD-40%) and RAVLT retention(BD-40%, DD-30%) tests. Evaluation of cognitive domains revealed impairment in memory and learning (80%), executive function (10%), visuo-spatial skills (30%), and language (30%).
CONCLUSION: Our results indicate that patients with PTCS can have significant cognitive impairment, particularly in learning and memory. The prevalence needs to be studied in a larger cohort. The relationship of cognitive impairment with chronically elevated intracranial pressures and its role in contributing to patient morbidity needs to be investigated further.

Entities:  

Mesh:

Year:  2011        PMID: 21606575      PMCID: PMC5378001          DOI: 10.3233/BEN-2011-0325

Source DB:  PubMed          Journal:  Behav Neurol        ISSN: 0953-4180            Impact factor:   3.342


  11 in total

Review 1.  Pediatric Intracranial Hypertension: a Current Literature Review.

Authors:  Shawn C Aylward; Amanda L Way
Journal:  Curr Pain Headache Rep       Date:  2018-02-13

Review 2.  The diagnosis and management of idiopathic intracranial hypertension and the associated headache.

Authors:  Rigmor Højland Jensen; Aleksandra Radojicic; Hanne Yri
Journal:  Ther Adv Neurol Disord       Date:  2016-03-21       Impact factor: 6.570

3.  Impaired glymphatic function in idiopathic intracranial hypertension.

Authors:  Per Kristian Eide; Are Hugo Pripp; Geir Ringstad; Lars Magnus Valnes
Journal:  Brain Commun       Date:  2021-03-21

4.  Cognitive function in idiopathic intracranial hypertension: a prospective case-control study.

Authors:  Hanne Maria Yri; Birgitte Fagerlund; Hysse Birgitte Forchhammer; Rigmor Højland Jensen
Journal:  BMJ Open       Date:  2014-04-08       Impact factor: 2.692

Review 5.  Idiopathic intracranial hypertension: ongoing clinical challenges and future prospects.

Authors:  Parunyou Julayanont; Amputch Karukote; Doungporn Ruthirago; Deepa Panikkath; Ragesh Panikkath
Journal:  J Pain Res       Date:  2016-02-19       Impact factor: 3.133

6.  Reversal of severe cognitive impairment following medical treatment of cystic invasive giant prolactinoma.

Authors:  J Bukowczan; K Lois; M Mathiopoulou; A B Grossman; R A James
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2016-02-09

7.  Inflammatory gene expression signatures in idiopathic intracranial hypertension: possible implications in microgravity-induced ICP elevation.

Authors:  Susana B Zanello; Vasisht Tadigotla; James Hurley; Johan Skog; Brian Stevens; Eusebia Calvillo; Eric Bershad
Journal:  NPJ Microgravity       Date:  2018-01-11       Impact factor: 4.415

8.  Cognitive performance in idiopathic intracranial hypertension and relevance of intracranial pressure.

Authors:  Olivia Grech; Andrew Clouter; James L Mitchell; Zerin Alimajstorovic; Ryan S Ottridge; Andreas Yiangou; Marianne Roque; Abd A Tahrani; Matthew Nicholls; Angela E Taylor; Fozia Shaheen; Wiebke Arlt; Gareth G Lavery; Kimron Shapiro; Susan P Mollan; Alexandra J Sinclair
Journal:  Brain Commun       Date:  2021-09-02

9.  The diagnostic dilemma of idiopathic intracranial hypertension in a child with acute lymphoblastic leukemia: COVID-19 or cytosine arabinoside?

Authors:  Rim Rakez; Wiem Boufrikha; Sana Lakhal; Amel Boughammoura; Mohamed Adnene Laatiri
Journal:  BMC Neurol       Date:  2022-05-02       Impact factor: 2.474

10.  Increased occurrence of pathological mitochondria in astrocytic perivascular endfoot processes and neurons of idiopathic intracranial hypertension.

Authors:  Per Kristian Eide; Md Mahdi Hasan-Olive; Hans-Arne Hansson; Rune Enger
Journal:  J Neurosci Res       Date:  2020-10-26       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.